BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21697283)

  • 1. Indirubins decrease glioma invasion by blocking migratory phenotypes in both the tumor and stromal endothelial cell compartments.
    Williams SP; Nowicki MO; Liu F; Press R; Godlewski J; Abdel-Rasoul M; Kaur B; Fernandez SA; Chiocca EA; Lawler SE
    Cancer Res; 2011 Aug; 71(16):5374-80. PubMed ID: 21697283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor effects of differentiation-inducing factor-1 in malignant melanoma: GSK-3-mediated inhibition of cell proliferation and GSK-3-independent suppression of cell migration and invasion.
    Arioka M; Takahashi-Yanaga F; Kubo M; Igawa K; Tomooka K; Sasaguri T
    Biochem Pharmacol; 2017 Aug; 138():31-48. PubMed ID: 28501501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3.
    Nowicki MO; Dmitrieva N; Stein AM; Cutter JL; Godlewski J; Saeki Y; Nita M; Berens ME; Sander LM; Newton HB; Chiocca EA; Lawler S
    Neuro Oncol; 2008 Oct; 10(5):690-9. PubMed ID: 18715951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell migration in paediatric glioma; characterisation and potential therapeutic targeting.
    Cockle JV; Picton S; Levesley J; Ilett E; Carcaboso AM; Short S; Steel LP; Melcher A; Lawler SE; Brüning-Richardson A
    Br J Cancer; 2015 Feb; 112(4):693-703. PubMed ID: 25628092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. δ-Catenin Promotes Bevacizumab-Induced Glioma Invasion.
    Shimizu T; Ishida J; Kurozumi K; Ichikawa T; Otani Y; Oka T; Tomita Y; Hattori Y; Uneda A; Matsumoto Y; Date I
    Mol Cancer Ther; 2019 Apr; 18(4):812-822. PubMed ID: 30872378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avasimibe inhibits the proliferation, migration and invasion of glioma cells by suppressing linc00339.
    Luo Y; Liu L; Li X; Shi Y
    Biomed Pharmacother; 2020 Oct; 130():110508. PubMed ID: 32682982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-asarone induces cell apoptosis, inhibits cell proliferation and decreases migration and invasion of glioma cells.
    Wang N; Han Y; Luo L; Zhang Q; Ning B; Fang Y
    Biomed Pharmacother; 2018 Oct; 106():655-664. PubMed ID: 29990855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of glioma cells by inactivating Wnt/β-catenin signaling.
    Tao Q; Wu C; Xu R; Niu L; Qin J; Liu N; Zhang P; Wang C
    Cell Tissue Res; 2017 Dec; 370(3):379-390. PubMed ID: 28815294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polarized regulation of glycogen synthase kinase-3β is important for glioma cell invasion.
    Zou Q; Hou Y; Shen F; Wang Y
    PLoS One; 2013; 8(12):e81814. PubMed ID: 24312592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
    Leclerc S; Garnier M; Hoessel R; Marko D; Bibb JA; Snyder GL; Greengard P; Biernat J; Wu YZ; Mandelkow EM; Eisenbrand G; Meijer L
    J Biol Chem; 2001 Jan; 276(1):251-60. PubMed ID: 11013232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artesunate attenuates glioma proliferation, migration and invasion by affecting cellular mechanical properties.
    Lian S; Shi R; Huang X; Hu X; Song B; Bai Y; Yang B; Dong J; Du Z; Zhang Y; Jia J; Ma N; Guo G; Wang M
    Oncol Rep; 2016 Aug; 36(2):984-90. PubMed ID: 27279152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marchantin C: a potential anti-invasion agent in glioma cells.
    Shen J; Li G; Liu Q; He Q; Gu J; Shi Y; Lou H
    Cancer Biol Ther; 2010 Jan; 9(1):33-9. PubMed ID: 19923918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exendin-4 inhibits glioma cell migration, invasion and epithelial-to-mesenchymal transition through GLP-1R/sirt3 pathway.
    Nie ZJ; Zhang YG; Chang YH; Li QY; Zhang YL
    Biomed Pharmacother; 2018 Oct; 106():1364-1369. PubMed ID: 30119208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival.
    Vajkoczy P; Knyazev P; Kunkel A; Capelle HH; Behrndt S; von Tengg-Kobligk H; Kiessling F; Eichelsbacher U; Essig M; Read TA; Erber R; Ullrich A
    Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5799-804. PubMed ID: 16585512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alphaxalone inhibits growth, migration and invasion of rat C6 malignant glioma cells.
    Sun H; Zheng X; Zhou Y; Zhu W; Ou Y; Shu M; Gao X; Leng T; Qiu P; Yan G
    Steroids; 2013 Oct; 78(10):1041-5. PubMed ID: 23831782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NEO212 Inhibits Migration and Invasion of Glioma Stem Cells.
    Marín-Ramos NI; Thein TZ; Cho HY; Swenson SD; Wang W; Schönthal AH; Chen TC; Hofman FM
    Mol Cancer Ther; 2018 Mar; 17(3):625-637. PubMed ID: 29440289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.
    Gwak HS; Park MJ; Park IC; Woo SH; Jin HO; Rhee CH; Jung HW
    J Neurosurg; 2014 Dec; 121(6):1483-91. PubMed ID: 25303017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of proline-rich tyrosine kinase 2 activation-mediated C6 glioma cell invasion after anti-vascular endothelial growth factor therapy.
    Xu CS; Wang ZF; Dai LM; Chu SH; Gong LL; Yang MH; Li ZQ
    J Transl Med; 2014 May; 12():148. PubMed ID: 24884636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells.
    Zhang X; Zheng K; Li C; Zhao Y; Li H; Liu X; Long Y; Yao J
    Oncol Rep; 2017 May; 37(5):2847-2856. PubMed ID: 28339056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.